Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers

    Forecasted

    This grant supports up to seven research centers to study genetic, clinical, and environmental factors in inflammatory bowel disease, aiming to improve diagnosis, prediction, and treatment through precision medicine.

    OverviewSimilar Grants
    OverviewSimilar Grants

    The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center

    This grant supports a center to coordinate genetic research, data, and biospecimen management for improving diagnosis and treatment of inflammatory bowel disease through the NIDDK IBD Genetics Consortium.

    HHS-NIH11Forecasted Nov 1, 2026· 6d$1,600,000Forecasted

    The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)

    This grant funds a consortium to study how the nervous system’s sensing of the gut affects GI disorders in adults and children, expanding research beyond gastroparesis to identify mechanisms, biomarkers, and new treatments.

    HHS-NIH11Forecasted Nov 1, 2026· 6d$1,500,000Forecasted

    The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)

    This grant funds a consortium to study and improve understanding of gastrointestinal disorders linked to impaired interoception, expanding research beyond gastroparesis to include other adult and pediatric GI conditions.

    HHS-NIH11Forecasted Nov 1, 2026· 6d$3,000,000Forecasted

    Academic Request for Proposals

    Provides academic researchers with access to IBD Plexus biosamples and datasets to advance diagnostics, therapies, and prevention for inflammatory bowel diseases.

    Crohns Colitis FoundationDue Oct 31, 2026· 5d

    2026 Inflammatory Bowel Disease (IBD) Fellowship – United States

    Pfizer's IBD Fellowship Grant funds US institutions to train gastroenterologists in innovative, equity-focused IBD research and care, emphasizing DEI and advanced technologies to improve patient outcomes.

    PfizerForecasted Apr 1, 2027$80,000Forecasted